[The chronocorrection of disorders in the blood coagulation rhythm with kurantil in patients with decompensated rheumatic heart defects].
The circadian pattern of hemocoagulation was studied in patients with decompensated rheumatic heart disease (DRHD) concurrent with stages I-II circulatory failure (CF) during complex treatment or medical treatment with disaggregants. Biorhythmological studies demonstrated that in patients with DRHD and CF chronotherapy with curantyl had some advantages over the traditional therapy during complex drug therapy. In these patients, the chronopatterns of circadian rhythms of hemocoagulative parameters tended to normalize under the influence of curantyl chronotherapy, by diminishing the signs of external desynchronization. Advantages of chronotherapy over the traditional treatment found in patients with DRHD and stages I-II CF, as manifested by its clinical effect in shorter periods (on days 4-5) when small daily and course doses of the drug were used. Based on the biorhythmological studies of hemostatic parameters, a method of curantyl chronotherapy was developed for patients with DRHD and stages I-II CF, which may optimize the therapeutical process in patients with this abnormality.
Zaslavskaia
R M
RM
Logvinenko
S I
SI
Logvinenko
A G
AG
Teĭblium
M M
MM
D000293:Adolescent; D000328:Adult; D001778:Blood Coagulation Disorders / Q000097:blood / Q000188:drug therapy*; D001780:Blood Coagulation Tests; D019454:Chronotherapy; D004176:Dipyridamole / Q000627:therapeutic use*; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012214:Rheumatic Heart Disease / Q000097:blood / Q000188:drug therapy*; D013997:Time Factors
D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole
Khronokorrektsiia narusheniĭ ritma gemokoaguliatsii kurantilom u bol'nykh s dekompensirovannymi revmaticheskimi porokami serdtsa.